Literature DB >> 22652081

Novel solvent-free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin.

Chellampillai Bothiraja1, Atmaram P Pawar, Ganesh Y Dama, Prajakta P Joshi, Karimunnisa S Shaikh.   

Abstract

INTRODUCTION: Various shortcomings of the available methods of extraction of plumbagin from Plumbago zeylanica using non-edible organic solvents coupled with the poor aqueous solubility and low bioavailability called for extracting plumbagin in a water soluble form via a single step technique using hydrophilic lipid Gelucire 44/14.
METHODS: Gelucire extract of P. zeylanica (GPZ) was prepared and evaluated for extraction efficiency, High-performance thin layer chromatography (HPTLC) and thermal analysis. In vitro intestinal absorption and bioavailability of plumbagin from GPZ in comparison with that of aqueous (APZ), ethanolic extract (EPZ) and standard plumbagin studied using non-everted rat intestinal sac model.
RESULTS: The GPZ showed significantly higher extraction efficiency (3.24±0.12% w/w) compared to ethanolic (EPZ) and aqueous (APZ) extraction, 2.48±0.16% w/w and 0.07±0.02% w/w respectively. GPZ displayed significantly higher Q(30min) (cumulative percentage absorption of plumbagin in 30 min) and lower t(40%) (time required for 40% w/w drug absorption). The flux and apparent permeability coefficient in duodenum and ileum were 2, 3 and 6 fold higher than EPZ, standard plumbagin and APZ respectively. DISCUSSION: Improved therapeutic efficacy of plumbagin may be due to the micellar solubilization and consequent enhanced partitioning of plumbagin through intestinal by Gelucire which was reflected in the in vivo anti-inflammatory study conducted in rats.
CONCLUSION: Thus extraction using Gelucire can be proclaimed as an efficient, economic and solvent-free technique for extraction of plumbagin and can be utilized for various clinically important water insoluble phytoconstituents in order to improve their biopharmaceutical properties.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652081     DOI: 10.1016/j.vascn.2012.05.007

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

1.  Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.

Authors:  Ahmed N Allam; Sherif I Hamdallah; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2017-07-04

2.  QbD based approach for optimization of Tenofovir disoproxil fumarate loaded liquid crystal precursor with improved permeability.

Authors:  Sharvil Patil; Chandrashekhar Kadam; Varsha Pokharkar
Journal:  J Adv Res       Date:  2017-07-29       Impact factor: 10.479

3.  Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation.

Authors:  May S Freag; Yosra S R Elnaggar; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2013-07-03

4.  Altered systemic bioavailability and organ distribution of azathioprine in methotrexate-induced intestinal mucositis in rats.

Authors:  Sadaf A Karbelkar; Anuradha S Majumdar
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

5.  Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology.

Authors:  Zenab Attari; Amita Bhandari; P C Jagadish; Shaila Lewis
Journal:  Saudi Pharm J       Date:  2015-03-20       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.